Evogene Ltd. (EVGN) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -203.1%, revenue growth -54.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $3.85M |
| Revenue (TTM) | $0.0B |
| Net Margin | -203.1% |
| Return on Equity | -65.4% |
| Operating Margin (TTM) | -364.2% |
| Current Ratio | 4.54 |
| Revenue Growth (YoY) | -54.7% |
| EPS Growth (YoY) | -137.4% |
| Industry P/E (Chemicals) | 32.1 |
| Sector P/E (Materials) | 23.9 |
EVGN overview · EVGN earnings · EVGN KPIs · EVGN documents · EVGN ownership · EVGN peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.